跳至主要内容
临床试验/NCT04625257
NCT04625257招募中不适用

COVID-19 in Baselland: Validation of Simple and Accurate Tests for COVID-19 Detection, Monitoring and Tracing (ACCURATE-BL-COVID-19)

University Hospital, Basel, Switzerland1 个研究点 分布在 1 个国家目标入组 1,600 人开始时间: 2020年10月24日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,600
试验地点
1
主要终点
qualitative method validation of the crude extraction in combination with the LAMP or the NGS (count values for detection)

研究概览

简要总结

This study is to establish an accurate, robust and easily scalable COVID-19 viral nucleic acid analysis platform from, but not limited to, saliva to help enable and support contact tracing in the canton of Baselland/ Switzerland. To achieve this, crude ribonucleotide acid (RNA) extraction from saliva is validated in combination with next-generation sequencing (NGS) diagnostics and loop mediated amplification (LAMP) assays as well as point of care test (POCT) for rapid detection of viral antigens on patients' samples.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • symptomatic patients getting tested for COVID-19

排除标准

  • mentally incompetent adults

结局指标

主要结局

qualitative method validation of the crude extraction in combination with the LAMP or the NGS (count values for detection)

时间窗: single point assessment at baseline

For all qualitative method validation, the qualitative and quantitative result of the Foederatio Analyticorum Medicinalium Helveticorum (FAMH) performed RT-PCR (patient does / does not have SARS-Cov-2 and if yes, how many "ct" values for detection) is considered as the gold standard against which the crude extraction in combination with the LAMP or the NGS method using univariate measures is compared.

次要结局

未报告次要终点

研究者

发起方
University Hospital, Basel, Switzerland
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

COVID-19 in Baselland: Validation of Simple and... | 临床试验